Request a Remote Demo
COVID-19 Amplifies Pharma’s Need for Digital Adherence Solutions
Injectable Diabetes Brand Increased Adherence by 2.9 Fills per Patient
Do Patients Taking Chronic Oncology Meds Deserve Rewarding Experiences Too?
Fast to Implement
Launch a branded program in just a few months with Drive; recruit patients right away with Max
Proven to Work
Support improved outcomes and generate revenue by boosting patient adherence
Built for the Life Sciences
Built to comply with the strictest requirements of the life sciences industry
Game mechanics like streaks, leaderboards and competitions engage patients and keep them returning to the platform
Concepts like loss aversion, optimism bias, fear of regret and reward substitution motivate patients to take action
The platform enables you to deliver targeted messaging, reward product use and capture insights from verified patients
Topical Acne Medication
A program for a leading branded topical acne medication improved adherence by 46%
Injectable Diabetes Medication
A leading branded injectable diabetes medication improved adherence by 57%
Inhaled COPD Medication
A COPD inhaled medication experienced a 58% lift in a difficult to engage patient population
Oral Hypertension Medication
Enrolled members’ adherence to an oral hypertension medication improved by 66%
Boehringer Ingelheim developed an adherence and engagement program for a daily respiratory inhaler, resulting in an increase in medication adherence of 2.8 fills over the program's initial period.
Find out how behavioral economics can help improve patient adherence in this article that details behavioral economics' power in engaging and motivating patients.